secwatch.observer — SEC 8-K summary
======================================

Issuer:     MoonLake Immunotherapeutics (MLTX)
CIK:        0001821586
Form:       8-K
Filed at:   2022-06-17T23:59:59+00:00
Accession:  0001213900-22-033592
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MoonLake Immunotherapeutics dismisses Withum and engages Baker Tilly as auditor post-merger
--------------------------------------------------------------------------------

- Audit Committee dismissed WithumSmith+Brown as independent auditor effective June 15, 2022.
- Baker Tilly US, LLP was engaged as the new independent registered public accounting firm on the same date.
- Withum's prior reports contained a going-concern paragraph related to the SPAC's pre-merger status; no disagreements or reportable events occurred.
- The business combination with MoonLake AG closed on April 5, 2022, resolving the going-concern uncertainty.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1821586/000121390022033592/0001213900-22-033592-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1821586/000121390022033592/ea161716-8k_moonlake.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-033592

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer